Legal & General Group’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.6M | Buy |
315,748
+62,288
| +25% | +$6.63M | 0.01% | 699 |
|
|
2025
Q1 | $23.1M | Buy |
253,460
+5,959
| +2% | +$542K | 0.01% | 766 |
|
|
2024
Q4 | $27.9M | Buy |
247,501
+35,434
| +17% | +$4M | 0.01% | 736 |
|
|
2024
Q3 | $25.2M | Buy |
212,067
+9,136
| +5% | +$1.08M | 0.01% | 770 |
|
|
2024
Q2 | $16.3M | Buy |
202,931
+32,759
| +19% | +$2.63M | ﹤0.01% | 906 |
|
|
2024
Q1 | $15.8M | Buy |
170,172
+12,146
| +8% | +$1.12M | ﹤0.01% | 924 |
|
|
2023
Q4 | $16.6M | Buy |
158,026
+22,182
| +16% | +$2.33M | 0.01% | 896 |
|
|
2023
Q3 | $14.8M | Buy |
135,844
+7,390
| +6% | +$805K | 0.01% | 907 |
|
|
2023
Q2 | $13.9M | Buy |
128,454
+26,718
| +26% | +$2.89M | ﹤0.01% | 954 |
|
|
2023
Q1 | $12.6M | Buy |
101,736
+7,235
| +8% | +$896K | ﹤0.01% | 960 |
|
|
2022
Q4 | $14.4M | Buy |
94,501
+3,195
| +3% | +$488K | 0.01% | 910 |
|
|
2022
Q3 | $12.3M | Buy |
91,306
+13,656
| +18% | +$1.84M | ﹤0.01% | 946 |
|
|
2022
Q2 | $11.6M | Buy |
77,650
+17,885
| +30% | +$2.67M | ﹤0.01% | 999 |
|
|
2022
Q1 | $10.2M | Buy |
59,765
+28,493
| +91% | +$4.89M | ﹤0.01% | 1145 |
|
|
2021
Q4 | $7.62M | Buy |
31,272
+4,769
| +18% | +$1.16M | ﹤0.01% | 1352 |
|
|
2021
Q3 | $7.33M | Buy |
26,503
+8,333
| +46% | +$2.31M | ﹤0.01% | 1340 |
|
|
2021
Q2 | $4.06M | Sell |
18,170
-25,301
| -58% | -$5.66M | ﹤0.01% | 1647 |
|
|
2021
Q1 | $4.75M | Sell |
43,471
-457
| -1% | -$49.9K | ﹤0.01% | 1576 |
|
|
2020
Q4 | $3.58M | Buy |
+43,928
| New | +$3.58M | ﹤0.01% | 1639 |
|